[
  {
    "ts": null,
    "headline": "Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note",
    "summary": "In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=c650b00dbec0e24e4237ed9efc61342c4bc75cc1152b65eb6d78c2e70309c68e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751493602,
      "headline": "Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note",
      "id": 135718139,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Abbott (ABT) stood at $134.11, denoting a -1.58% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=c650b00dbec0e24e4237ed9efc61342c4bc75cc1152b65eb6d78c2e70309c68e"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Upgraded to Buy: Here's What You Should Know",
    "summary": "Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
    "url": "https://finnhub.io/api/news?id=12300f4b091ba5c3672d7efc04befbf25e06b61fabbda456ea4aa7567fe50e09",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751472003,
      "headline": "Abbott (ABT) Upgraded to Buy: Here's What You Should Know",
      "id": 135718140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
      "url": "https://finnhub.io/api/news?id=12300f4b091ba5c3672d7efc04befbf25e06b61fabbda456ea4aa7567fe50e09"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion",
    "summary": "ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.",
    "url": "https://finnhub.io/api/news?id=81ae155aa40db5e40f2f69234b452355d2cfbb3734e1c941c749756ab62910a1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751464860,
      "headline": "Abbott Sees Upside on Diagnostics Growth, FreeStyle Libre Expansion",
      "id": 135714146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "ABT stock surges 21.7% year to date on CGM sales growth and robust diagnostics demand, even as FX and macro risks weigh on forecasts.",
      "url": "https://finnhub.io/api/news?id=81ae155aa40db5e40f2f69234b452355d2cfbb3734e1c941c749756ab62910a1"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Amarin (AMRN) This Year?",
    "summary": "Here is how Amarin (AMRN) and Abbott (ABT) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=cc6cc423497b11782e878ea3146290c022dc2ed0a81f2d4d5f7d3cfc3563df21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751463603,
      "headline": "Are Medical Stocks Lagging  Amarin (AMRN) This Year?",
      "id": 135714147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Here is how Amarin (AMRN) and Abbott (ABT) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=cc6cc423497b11782e878ea3146290c022dc2ed0a81f2d4d5f7d3cfc3563df21"
    }
  },
  {
    "ts": null,
    "headline": "Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern",
    "summary": "HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.",
    "url": "https://finnhub.io/api/news?id=d7ac75371422a131a5647f54ac9caf03a9540e0e7554b0f74f568ffeb854a616",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751463300,
      "headline": "Hologic Faces Molecular Drag, But Here's Why It's Not a Major Concern",
      "id": 135713767,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "HOLX's Molecular Diagnostics growth stays resilient, as new assays and test adoption offset funding headwinds.",
      "url": "https://finnhub.io/api/news?id=d7ac75371422a131a5647f54ac9caf03a9540e0e7554b0f74f568ffeb854a616"
    }
  },
  {
    "ts": null,
    "headline": "Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock",
    "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=b3021dc92fa6a3f6b064e46cd1eb3797a6a36ae2b4ba45e66526e514050b4a0c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751461202,
      "headline": "Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock",
      "id": 135714149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=b3021dc92fa6a3f6b064e46cd1eb3797a6a36ae2b4ba45e66526e514050b4a0c"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital",
    "summary": "If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...",
    "url": "https://finnhub.io/api/news?id=7dbdf4fc6c7bf8c511836c241978d20af2b241a09ef3505811d955e95f389223",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751454019,
      "headline": "Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital",
      "id": 135711195,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...",
      "url": "https://finnhub.io/api/news?id=7dbdf4fc6c7bf8c511836c241978d20af2b241a09ef3505811d955e95f389223"
    }
  }
]